Commercial Strategy
The best device doesn’t always win. The best-positioned one does. We help you choose the right market, define a differentiated position, and confirm the opportunity justifies the investment.
Please feel out the form below and someone from our team will contact you shortly.

Overview
Commercial strategy sets the direction for every commercial decision that follows. We help biomedical innovators size the opportunity, build a sustainable business model, and bring market input into product requirements before major capital is committed to clinical, regulatory, and launch work. The result is a plan investors can back and your team can execute.
What commercial strategy covers
Commercial strategy turns a promising device into a defensible business. Our work helps you size the market, define how you’ll generate revenue, and confirm that what you’re building is what the market will buy.
-
Market & Investor Strategy
Market assessment, forecasting, fundraising narrative, commercial due diligence, partnerships, and exit readiness that build long-term value.
-
Business Model Strategy
Revenue model, channel priorities, sales strategy, cost structure, and path to profitability, defined before you commit to a market.
-
Product Strategy
Commercial input on product requirements and portfolio decisions, coordinated with your design and development teams.
Where commercial strategy shows up
Commercial strategy should lead at Foundation. That is where you set the market, business model, and investor case that later commercial decisions build on. It should then be revisited as evidence comes in and market conditions change.
PHASE 0
Foundation
Leads market assessment, business model, and investor strategy.
PHASE 1
Clinical Evidence
Supports the fundraising narrative and partnership strategy.
PHASE 2
Pivotal Development
Supports forecast and business model updates ahead of data readout.
PHASE 3
Regulatory Submission
Supports sales strategy and channel priorities ahead of clearance.
PHASE 4
Market Clearance
Supports channel partner selection and sales model.
PHASE 5
Commercial Launch
Supports forecast tracking and sales strategy adjustments.
PHASE 6
Growth
Leads portfolio, partnership, and exit readiness strategy.
The ROI on better commercial strategy
The commercial decisions you make early shape what you can raise, what you can charge, and how fast you reach revenue. A strategy grounded in real market data gives your device its best chance of winning the market, not just reaching it.
Stronger Fundraising
A market case and investor narrative that hold up to due diligence.
Focused Investment
Capital directed to the markets and indications worth pursuing.
Clear Path to Profitability
A business model with defined revenue, channels, and cost structure.
Faster Time to Revenue
Key commercial decisions settled before they can slow down launch.
Explore our disciplines
Every program draws on a different combination of our core disciplines to build the path from innovation to adoption.
-
Market Access
Build the path to payment and purchase, from coding and coverage to contracts.
-
Evidence & Insights
Ground commercial decisions in what clinicians, payers, and buyers need to see.
-
Go-to-Market
Turn strategy into launch plans and marketing programs that drive adoption.
-
Commercial Strategy
Choose the right market, define a differentiated position, and confirm the opportunity justifies the investment